Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
<p><b>Background</b></p> The purpose of this 6-month intervention pilot feasibility randomised trial was to test sending brief messages using mobile phones to promote self-management through taking medication as prescribed to people with type 2 diabetes. This was to inform th...
Main Authors: | Farmer, AJ, Allen, J, Bartlett, YK, Bower, P, Chi, Y, French, DP, Gudgin, B, Holmes, E, Horne, R, Hughes, DA, Jones, L, Kenning, C, Locock, L, McSharry, J, Miles, L, Newhouse, N, Rea, R, Robinson, S, Tarassenko, L, Velardo, C, Williams, N, Yu, L |
---|---|
Other Authors: | SuMMiT-D Collaborative Group |
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2024
|
Similar Items
-
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocol
by: Farmer, A, et al.
Published: (2019) -
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D Feasibility): a randomised feasibility trial protocol
by: Peter Bower, et al.
Published: (2019-12-01) -
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
by: The SuMMiT-D Collaborative Group, et al.
Published: (2024-01-01) -
Understanding acceptability in the context of text messages to encourage medication adherence in people with type 2 diabetes
by: Bartlett, YK, et al.
Published: (2021) -
System architecture for "Support through Mobile Messaging and Digital Health Technology for Diabetes" (SuMMiT-D): Design and performance in pilot and randomized controlled feasibility studies
by: Chi, Y, et al.
Published: (2021)